| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,419 |
4,792 |
$185K |
| 80053 |
Comprehensive metabolic panel |
10,528 |
8,211 |
$147K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,390 |
1,920 |
$133K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,563 |
1,301 |
$113K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,418 |
2,030 |
$107K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
9,201 |
4,126 |
$93K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,031 |
1,105 |
$85K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,662 |
6,003 |
$73K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,206 |
9,376 |
$65K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
366 |
310 |
$49K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,819 |
1,488 |
$47K |
| 80050 |
General health panel |
1,289 |
1,033 |
$45K |
| 36415 |
Collection of venous blood by venipuncture |
8,395 |
6,206 |
$45K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,633 |
1,355 |
$39K |
| 71046 |
Radiologic examination, chest; 2 views |
3,014 |
2,456 |
$39K |
| 87081 |
|
4,089 |
3,672 |
$33K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,726 |
2,931 |
$30K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
235 |
220 |
$28K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
533 |
520 |
$27K |
| 87400 |
|
4,265 |
2,269 |
$25K |
| 84484 |
|
4,271 |
2,402 |
$24K |
| 80061 |
Lipid panel |
2,840 |
2,249 |
$24K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,140 |
1,628 |
$18K |
| 82553 |
|
2,033 |
1,452 |
$15K |
| 81001 |
|
4,731 |
3,978 |
$14K |
| 71045 |
Radiologic examination, chest; single view |
2,649 |
2,138 |
$14K |
| 81025 |
|
1,698 |
1,476 |
$13K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,940 |
1,563 |
$13K |
| 86710 |
|
693 |
653 |
$12K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
237 |
202 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
522 |
316 |
$11K |
| 84703 |
|
1,152 |
978 |
$10K |
| 82550 |
|
2,160 |
1,548 |
$10K |
| 83735 |
|
2,256 |
1,718 |
$9K |
| 83880 |
|
761 |
579 |
$9K |
| 94760 |
|
900 |
427 |
$9K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,447 |
1,238 |
$9K |
| 87807 |
|
747 |
676 |
$9K |
| 81003 |
|
3,424 |
2,851 |
$8K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
150 |
142 |
$8K |
| 83690 |
|
1,404 |
1,103 |
$8K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,586 |
1,270 |
$7K |
| 87088 |
|
1,011 |
873 |
$6K |
| 80306 |
|
380 |
305 |
$6K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
204 |
90 |
$6K |
| 83605 |
|
903 |
645 |
$6K |
| 97161 |
|
433 |
306 |
$6K |
| 87186 |
|
1,193 |
1,018 |
$5K |
| 82150 |
|
871 |
726 |
$5K |
| 87040 |
|
637 |
330 |
$5K |
| 87420 |
|
399 |
367 |
$5K |
| 80320 |
|
286 |
219 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
148 |
124 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,446 |
1,174 |
$4K |
| 74018 |
|
254 |
217 |
$3K |
| 87077 |
|
496 |
423 |
$3K |
| 80143 |
|
158 |
125 |
$3K |
| 80179 |
|
147 |
112 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
998 |
771 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
358 |
297 |
$3K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
29 |
24 |
$2K |
| 84436 |
|
775 |
612 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
86 |
67 |
$2K |
| 97010 |
|
811 |
222 |
$2K |
| 71020 |
|
155 |
138 |
$2K |
| 73630 |
|
100 |
76 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
560 |
467 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
183 |
163 |
$2K |
| 73030 |
|
77 |
63 |
$2K |
| 82077 |
|
98 |
77 |
$1K |
| 73610 |
|
115 |
84 |
$1K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
54 |
27 |
$1K |
| 85610 |
|
611 |
471 |
$1K |
| 84439 |
|
122 |
104 |
$1K |
| 85027 |
|
171 |
141 |
$991.25 |
| G0378 |
Hospital observation service, per hour |
318 |
138 |
$923.32 |
| 72100 |
|
56 |
50 |
$895.34 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
282 |
160 |
$778.05 |
| 85007 |
|
150 |
123 |
$614.28 |
| 80047 |
|
30 |
28 |
$586.92 |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
12 |
12 |
$559.06 |
| 82962 |
|
120 |
64 |
$504.26 |
| 85730 |
|
136 |
108 |
$446.50 |
| 73502 |
|
20 |
14 |
$398.44 |
| 80329 |
|
53 |
40 |
$388.08 |
| 73562 |
|
14 |
13 |
$340.00 |
| 83655 |
|
16 |
14 |
$241.92 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
29 |
24 |
$226.30 |
| 90715 |
|
13 |
12 |
$115.20 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
303 |
192 |
$114.00 |
| 71010 |
|
14 |
12 |
$108.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14 |
12 |
$86.25 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
32 |
26 |
$54.29 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,287 |
945 |
$14.60 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
15 |
12 |
$8.91 |
| J7510 |
Prednisolone oral, per 5 mg |
29 |
24 |
$5.17 |
| A9270 |
Non-covered item or service |
3,951 |
556 |
$0.10 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
14 |
12 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12 |
12 |
$0.00 |